Cargando…
Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, incl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586927/ https://www.ncbi.nlm.nih.gov/pubmed/36271282 http://dx.doi.org/10.1038/s41598-022-21851-8 |
_version_ | 1784813793007632384 |
---|---|
author | Galiniak, Sabina Podgórski, Rafał Rachel, Marta Mazur, Artur |
author_facet | Galiniak, Sabina Podgórski, Rafał Rachel, Marta Mazur, Artur |
author_sort | Galiniak, Sabina |
collection | PubMed |
description | The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF. |
format | Online Article Text |
id | pubmed-9586927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95869272022-10-23 Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study Galiniak, Sabina Podgórski, Rafał Rachel, Marta Mazur, Artur Sci Rep Article The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF. Nature Publishing Group UK 2022-10-21 /pmc/articles/PMC9586927/ /pubmed/36271282 http://dx.doi.org/10.1038/s41598-022-21851-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Galiniak, Sabina Podgórski, Rafał Rachel, Marta Mazur, Artur Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_full | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_fullStr | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_full_unstemmed | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_short | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_sort | serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586927/ https://www.ncbi.nlm.nih.gov/pubmed/36271282 http://dx.doi.org/10.1038/s41598-022-21851-8 |
work_keys_str_mv | AT galiniaksabina serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy AT podgorskirafał serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy AT rachelmarta serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy AT mazurartur serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy |